Deepak Nitrite invests ₹175 crore in subsidiary via OCRPS
- Deepak Nitrite and Deepak Phenolics invested ₹175 crore in Deepak Chem Tech
- Investment made via 9% OCRPS allotment on August 26, 2026
- Funds aim to support project expenses and general corporate purposes
- Subsidiary turnover grew to ₹172.23 crore in FY26 from ₹9.43 crore in FY25

*this image is generated using AI for illustrative purposes only.
Deepak Nitrite Limited Deepak Nitrite and its wholly owned subsidiary Deepak Phenolics Limited have jointly invested ₹175 crore in another subsidiary, Deepak Chem Tech Limited. The investment was executed through the allotment of Optionally Convertible Redeemable Preference Shares (OCRPS) on August 26, 2026.
The transaction involves two distinct allotments to strengthen the capital base of Deepak Chem Tech Limited, which operates plants for fluorination, nitric acid, nitration, and hydrogenation. Deepak Phenolics Limited acquired 95 lakh OCRPS at a face value of ₹100 each, aggregating to ₹95 crore. Simultaneously, Deepak Nitrite Limited allotted 80 lakh OCRPS at par, totaling ₹80 crore. Both transactions were conducted at an arms-length basis.
Transaction Details
The OCRPS carry a coupon rate of 9%. The consideration was paid in cash through normal banking channels. This infusion is intended to support Deepak Chem Tech Limited in meeting project expenses across various sites in Gujarat and for general corporate purposes. No governmental or regulatory approvals were required for this acquisition.
| Allottee | Number of OCRPS | Face Value | Total Amount | Coupon Rate |
|---|---|---|---|---|
| Deepak Phenolics Ltd | 95,00,000 | ₹100 | ₹95 crore | 9% |
| Deepak Nitrite Ltd | 80,00,000 | ₹100 | ₹80 crore | 9% |
Subsidiary Financial Context
Deepak Chem Tech Limited reported a turnover of ₹172.23 crore for FY26, a significant increase from ₹9.43 crore in FY25 and ₹0.86 crore in FY24. Prior to this allotment, the subsidiary’s paid-up capital stood at ₹2,744.5 crore, comprising ₹499.50 crore in equity shares and ₹2,245 crore in preference shares.
What the Numbers Show
The turnover growth trajectory indicates rapid operational scaling. Revenue expanded from less than ₹1 crore in FY24 to over ₹172 crore in FY26. This three-year progression suggests that the recent ₹175 crore capital infusion is likely aligned with supporting this accelerated expansion phase rather than initial setup costs, given the subsidiary already has substantial existing paid-up capital.
Historical Stock Returns for Deepak Nitrite
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.77% | +0.13% | +5.94% | +10.67% | -3.33% | 0.0% |
How will the 9% coupon liability on the ₹175 crore OCRPS issuance impact Deepak Chem Tech's net profit margins and cash flow projections for FY27?
Which specific capacity expansion projects in Gujarat are prioritized with this capital infusion, and what is the expected timeline for their commissioning?
Given the subsidiary's exponential revenue growth from ₹0.86 crore to ₹172.23 crore in two years, what operational bottlenecks is this capital intended to resolve to sustain this trajectory?


































